Almotriptan

Generic name: Pronounced as (al moh trip' tan)
Brand names
  • Axert®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 03/15/2016

Almotriptan is used to treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Almotriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels around the brain, stopping pain signals from being sent to the brain, and blocking the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Almotriptan does not prevent migraine attacks or reduce the number of headaches you have.

Almotriptan comes as a tablet to take by mouth. It is usually taken at the first sign of a migraine headache. If your symptoms improve after you take almotriptan but return after 2 hours or longer, you may take a second tablet. However, if your symptoms do not improve after you take almotriptan, do not take a second tablet before calling your doctor. Your doctor will tell you the maximum number of tablets you may take in a 24-hour period. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take almotriptan exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

You may take your first dose of almotriptan in a doctor's office or other medical facility where you can be monitored for serious reactions.

Call your doctor if your headaches do not get better or occur more frequently after taking almotriptan.

If you take almotriptan more often or for longer than the recommended period of time, your headaches may get worse or may occur more frequently. You should not take almotriptan or any other headache medication for more than 10 days per month. Call your doctor if you need to take almotriptan to treat more than four headaches in a 1-month period.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking almotriptan,

  • tell your doctor and pharmacist if you are allergic to almotriptan, any other medications, or any of the ingredients in almotriptan tablets. Ask your pharmacist for a list of the ingredients.

  • do not take almotriptan if you have taken any of the following medications in the past 24 hours: other selective serotonin receptor agonists such as eletriptan (Relpax), frovatriptan (Frova), naratriptan (Amerge), rizatriptan (Maxalt), sumatriptan (Imitrex, in Treximet), or zolmitriptan (Zomig); or ergot-type medications such as bromocriptine (Parlodel), cabergoline, dihydroergotamine (D.H.E. 45, Migranal), ergoloid mesylates (Hydergine), ergonovine (Ergotrate), ergotamine (Cafergot, Ergomar, Wigraine), methylergonovine (Methergine), methysergide (Sansert), and pergolide (Permax).

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking, have recently stopped taking, or plan to take. Be sure to mention any of the following: acetaminophen (Tylenol); aspirin and other nonsteroidal anti-inflammatory medications (NSAIDS) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); clarithromycin (Biaxin); indinavir (Crixivan); ; nefazodone (Serzone); selective serotonin reuptake inhibitors (SSRIs) such as citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac, Sarafem, in Symbyax), fluvoxamine, paroxetine (Paxil), and sertraline (Zoloft); selective serotonin/norepinephrine reuptake inhibitors (SNRIs) such as desvenlafaxine (Pristiq), duloxetine (Cymbalta), sibutramine (Meridia), and venlafaxine (Effexor); troleandomycin (TAO); and zafirlukast (Accolate). Tell your doctor or pharmacist if you are taking the following medications or if you have stopped taking them within the past week: antifungals such as itraconazole (Sporanox) and ketoconazole (Nizoral); erythromycin (E.E.S., E-Mycin, Erythrocin); and ritonavir (Norvir). Also tell your doctor or pharmacist if you are taking the following medications or if you have stopped taking them within the past 2 weeks: monoamine oxidase (MAO) inhibitors, including isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Eldepryl), and tranylcypromine (Parnate). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had heart disease; a heart attack; angina (chest pain); irregular heartbeats; stroke or 'mini-stroke'; or circulation problems such as varicose veins, blood clots in the legs, Raynaud's disease (problems with blood flow to the fingers, toes, ears, and nose), or ischemic bowel disease (bloody diarrhea and stomach pain caused by decreased blood flow to the intestines). Your doctor may tell you not to take almotriptan.

  • tell your doctor if you smoke or are overweight; if you have or have ever had high blood pressure, high cholesterol, diabetes, or kidney or liver disease; if you have gone through menopause (change of life); or if any family members have or have ever had heart disease or stroke.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you plan to be sexually active while you are taking this medication, talk to your doctor about effective methods of birth control. If you become pregnant while taking almotriptan, call your doctor.

  • you should know that almotriptan may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

  • talk to your doctor about your headache symptoms to make sure they are caused by migraine. Almotriptan should not be used to treat hemiplegic or basilar migraine or headaches caused by other conditions (such as cluster headaches).

Talk to your doctor about drinking grapefruit juice while taking this medicine.

  • Almotriptan may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • upset stomach

    • nausea

    • drowsiness

    • headache

    • dry mouth

    • dizziness

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

    • swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs

    • hoarseness

    • hives

    • rash

    • itching

    • tightness, pain, pressure, or heaviness in the chest, throat, neck, or jaw

    • slow or difficult speech

    • faintness

    • weakness or numbness of an arm or leg

    • sudden or severe stomach pain

    • bloody diarrhea

    • rapid, pounding, or irregular heartbeat

    • shortness of breath

    • breaking out in a cold sweat

    • difficulty breathing or swallowing

    • paleness or blue color of the fingers and toes

    • pain, burning, or tingling in the hands or feet

  • Almotriptan may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor. Your blood pressure should be checked regularly.

You should keep a headache diary by writing down when you have headaches and when you take almotriptan.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Repaglinide Repaglinide The metabolism of Almotriptan can be decreased when combined with Repaglinide.
Montelukast Montelukast The metabolism of Almotriptan can be decreased when combined with Montelukast.
Delavirdine Delavirdine The metabolism of Almotriptan can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Almotriptan can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Almotriptan.
Dolasetron Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Almotriptan.
Candesartan Candesartan The metabolism of Almotriptan can be decreased when combined with Candesartan.
Cilostazol Cilostazol Almotriptan may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Clopidogrel Clopidogrel The metabolism of Almotriptan can be decreased when combined with Clopidogrel.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Almotriptan is combined with Diphenoxylate.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Fenofibrate Fenofibrate Almotriptan may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Almotriptan is combined with Guanfacine.
Magnesium Hydroxide Magnesium Hydroxide Almotriptan may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine Methylergonovine Methylergometrine may increase the vasoconstricting activities of Almotriptan.
Mycophenolate Mycophenolate Almotriptan may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Naratriptan.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Paregoric Paregoric The metabolism of Almotriptan can be decreased when combined with Morphine.
Penbutolol Penbutolol The metabolism of Almotriptan can be decreased when combined with Acebutolol.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Almotriptan.
Potassium Potassium Potassium may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Prednisone may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Ranitidine Ranitidine The metabolism of Almotriptan can be decreased when combined with Ranitidine.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Almotriptan.
Rizatriptan Rizatriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Rizatriptan.
Sumatriptan Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Almotriptan.
Tacrolimus Tacrolimus Tacrolimus may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Tizanidine Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Almotriptan.
Zolmitriptan Zolmitriptan The risk or severity of vasospastic reactions can be increased when Zolmitriptan is combined with Almotriptan.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection Fluconazole may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Almotriptan.
Levofloxacin Injection Levofloxacin Injection Almotriptan may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Almotriptan.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Almotriptan is combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The metabolism of Almotriptan can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The metabolism of Almotriptan can be decreased when combined with Morphine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Almotriptan may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The metabolism of Almotriptan can be decreased when combined with Zidovudine.
Altretamine Altretamine The metabolism of Almotriptan can be decreased when combined with Amphetamine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Almotriptan.
Ondansetron Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Almotriptan.
Granisetron Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Almotriptan.
Torsemide Torsemide The metabolism of Almotriptan can be decreased when combined with Torasemide.
Olanzapine Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Almotriptan.
Alosetron Alosetron The risk or severity of adverse effects can be increased when Almotriptan is combined with Alosetron.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Almotriptan.
Eprosartan Eprosartan Almotriptan may decrease the antihypertensive activities of Eprosartan.
Hydroxychloroquine Hydroxychloroquine The metabolism of Almotriptan can be decreased when combined with Hydroxychloroquine.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Oxcarbazepine Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Almotriptan.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Telmisartan Telmisartan Almotriptan may decrease the antihypertensive activities of Telmisartan.
Temozolomide Temozolomide Temozolomide may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Zaleplon Zaleplon Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.
Anakinra Anakinra The metabolism of Almotriptan can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Almotriptan is combined with Desloratadine.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Almotriptan.
Trimipramine Trimipramine The metabolism of Almotriptan can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Almotriptan can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Perindopril Perindopril Perindopril may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Dutasteride Dutasteride The risk or severity of hypertension can be increased when Almotriptan is combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The risk or severity of hypertension can be increased when Epinephrine is combined with Almotriptan.
Eplerenone Eplerenone Almotriptan may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Escitalopram.
Olmesartan Olmesartan Almotriptan may decrease the antihypertensive activities of Olmesartan.
Zonisamide Zonisamide The metabolism of Almotriptan can be decreased when combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Almotriptan can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of adverse effects can be increased when Almotriptan is combined with Aripiprazole.
Atomoxetine Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Almotriptan.
Dexmethylphenidate Dexmethylphenidate The risk or severity of adverse effects can be increased when Almotriptan is combined with Dexmethylphenidate.
Atazanavir Atazanavir The metabolism of Almotriptan can be decreased when combined with Atazanavir.
Eletriptan Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Almotriptan.
Mefloquine Mefloquine The metabolism of Almotriptan can be decreased when combined with Mefloquine.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Memantine Memantine Almotriptan may decrease the excretion rate of Memantine which could result in a higher serum level.
Tegaserod Tegaserod The metabolism of Tegaserod can be decreased when combined with Almotriptan.
Tadalafil Tadalafil Almotriptan may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Frovatriptan Frovatriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Frovatriptan.
Progesterone Progesterone The metabolism of Almotriptan can be decreased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Almotriptan.
Infliximab Injection Infliximab Injection The metabolism of Almotriptan can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Almotriptan.
Rifaximin Rifaximin The metabolism of Almotriptan can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Almotriptan.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Trospium Trospium Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan Almotriptan may decrease the antihypertensive activities of Bosentan.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Almotriptan can be decreased when combined with Cinacalcet.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Almotriptan can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Almotriptan is combined with Eszopiclone.
Ganciclovir Ganciclovir Almotriptan may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Solifenacin Solifenacin Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Valganciclovir Valganciclovir Almotriptan may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Almotriptan can be decreased when combined with Voriconazole.
Adefovir Adefovir Adefovir may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine The metabolism of Almotriptan can be decreased when combined with Amphetamine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Almotriptan can be decreased when combined with Peginterferon alfa-2b.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Isocarboxazid Isocarboxazid The metabolism of Almotriptan can be decreased when combined with Isocarboxazid.
Ramelteon Ramelteon The risk or severity of adverse effects can be increased when Almotriptan is combined with Ramelteon.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Almotriptan.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Almotriptan.
Pregabalin Pregabalin The therapeutic efficacy of Almotriptan can be increased when used in combination with Pregabalin.
Deferasirox Deferasirox The metabolism of Almotriptan can be decreased when combined with Deferasirox.
Phenylephrine Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Almotriptan.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Almotriptan.
Felbamate Felbamate The risk or severity of adverse effects can be increased when Almotriptan is combined with Felbamate.
Ranolazine Ranolazine The serum concentration of Almotriptan can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Almotriptan can be increased when combined with Abatacept.
Rasagiline Rasagiline The metabolism of Almotriptan can be decreased when combined with Rasagiline.
Imatinib Imatinib The metabolism of Almotriptan can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The metabolism of Sitagliptin can be decreased when combined with Almotriptan.
Varenicline Varenicline Almotriptan may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib Gefitinib The metabolism of Almotriptan can be decreased when combined with Gefitinib.
Albuterol Albuterol Almotriptan may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone The risk or severity of adverse effects can be increased when Almotriptan is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Almotriptan can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Clofarabine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Lubiprostone Lubiprostone Almotriptan may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Posaconazole Posaconazole The metabolism of Almotriptan can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Almotriptan can be decreased when combined with Primaquine.
Aliskiren Aliskiren Almotriptan may decrease the antihypertensive activities of Aliskiren.
Darunavir Darunavir The metabolism of Darunavir can be decreased when combined with Almotriptan.
Pemetrexed Injection Pemetrexed Injection Almotriptan may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of adverse effects can be increased when Almotriptan is combined with Dimenhydrinate.
Lisdexamfetamine Lisdexamfetamine The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Lisdexamfetamine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Sorafenib Sorafenib The metabolism of Almotriptan can be decreased when combined with Sorafenib.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Lapatinib Lapatinib The metabolism of Almotriptan can be decreased when combined with Lapatinib.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Almotriptan is combined with Levocetirizine.
Pegaptanib Injection Pegaptanib Injection Almotriptan may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Mexiletine Mexiletine The metabolism of Almotriptan can be decreased when combined with Mexiletine.
Azacitidine Injection Azacitidine Injection Almotriptan may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Temsirolimus Temsirolimus The metabolism of Almotriptan can be decreased when combined with Temsirolimus.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Nilotinib Nilotinib The metabolism of Almotriptan can be decreased when combined with Nilotinib.
Bexarotene Bexarotene The metabolism of Almotriptan can be decreased when combined with Bexarotene.
Budesonide Budesonide Almotriptan may decrease the excretion rate of Budesonide which could result in a higher serum level.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Almotriptan.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Almotriptan.
Doripenem Injection Doripenem Injection Almotriptan may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection Almotriptan may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine The risk or severity of adverse effects can be increased when Almotriptan is combined with Desvenlafaxine.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Nebivolol Nebivolol Almotriptan may decrease the antihypertensive activities of Nebivolol.
Tretinoin Tretinoin The metabolism of Almotriptan can be decreased when combined with Tretinoin.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Almotriptan.
Certolizumab Injection Certolizumab Injection The metabolism of Almotriptan can be increased when combined with Certolizumab pegol.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Almotriptan may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Almotriptan.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Almotriptan.
Naltrexone Injection Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Almotriptan.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Almotriptan can be decreased when combined with Eltrombopag.
Milnacipran Milnacipran The risk or severity of adverse effects can be increased when Almotriptan is combined with Milnacipran.
Plerixafor Injection Plerixafor Injection Almotriptan may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Betaxolol Betaxolol The metabolism of Almotriptan can be decreased when combined with Betaxolol.
Iloperidone Iloperidone The risk or severity of adverse effects can be increased when Almotriptan is combined with Iloperidone.
Prasugrel Prasugrel Almotriptan may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide The risk or severity of adverse effects can be increased when Almotriptan is combined with Lacosamide.
Everolimus Everolimus The metabolism of Almotriptan can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Almotriptan.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Almotriptan.
Pralatrexate Injection Pralatrexate Injection Almotriptan may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Almotriptan.
Saxagliptin Saxagliptin Almotriptan may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Almotriptan may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Topotecan Topotecan Almotriptan may decrease the excretion rate of Topotecan which could result in a higher serum level.
Golimumab Injection Golimumab Injection The metabolism of Almotriptan can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Almotriptan.
Asenapine Asenapine The risk or severity of adverse effects can be increased when Almotriptan is combined with Asenapine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Almotriptan is combined with Vigabatrin.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Almotriptan.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Almotriptan is combined with Oxymorphone.
Tocilizumab Injection Tocilizumab Injection The metabolism of Almotriptan can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Almotriptan may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Almotriptan.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Almotriptan.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of adverse effects can be increased when Almotriptan is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Almotriptan.
Ipilimumab Injection Ipilimumab Injection Almotriptan may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Terbutaline may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Roflumilast Roflumilast Almotriptan may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Rilpivirine Rilpivirine The metabolism of Almotriptan can be decreased when combined with Rilpivirine.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Almotriptan can be increased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Almotriptan can be decreased when combined with Abiraterone.
Rivaroxaban Rivaroxaban Almotriptan may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ruxolitinib Ruxolitinib Almotriptan may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam Clobazam The metabolism of Almotriptan can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The metabolism of Almotriptan can be decreased when combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Almotriptan can be decreased when combined with Vismodegib.
Deferiprone Deferiprone Almotriptan may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Cabergoline Cabergoline Cabergoline may increase the vasoconstricting activities of Almotriptan.
Naloxone Injection Naloxone Injection The metabolism of Almotriptan can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan Almotriptan may decrease the antihypertensive activities of Ambrisentan.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Almotriptan.
Enzalutamide Enzalutamide The metabolism of Almotriptan can be decreased when combined with Enzalutamide.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Almotriptan.
Regorafenib Regorafenib The metabolism of Almotriptan can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Almotriptan can be decreased when combined with Bosutinib.
Teriflunomide Teriflunomide The metabolism of Almotriptan can be decreased when combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Almotriptan can be decreased when combined with Cabozantinib.
Teduglutide Injection Teduglutide Injection Almotriptan may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Alogliptin Alogliptin Almotriptan may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Ponatinib Ponatinib The metabolism of Almotriptan can be decreased when combined with Ponatinib.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Almotriptan is combined with Pomalidomide.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Almotriptan.
Canagliflozin Canagliflozin Almotriptan may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The metabolism of Almotriptan can be decreased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Almotriptan can be decreased when combined with Ospemifene.
Trametinib Trametinib The metabolism of Almotriptan can be decreased when combined with Trametinib.
Levomilnacipran Levomilnacipran The risk or severity of adverse effects can be increased when Almotriptan is combined with Levomilnacipran.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Almotriptan.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Almotriptan.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Sofosbuvir Sofosbuvir Almotriptan may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin Dapagliflozin may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast Apremilast The metabolism of Almotriptan can be increased when combined with Apremilast.
Droxidopa Droxidopa Almotriptan may increase the hypertensive activities of Droxidopa.
Siltuximab Injection Siltuximab Injection The metabolism of Almotriptan can be increased when combined with Siltuximab.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Almotriptan is combined with Eslicarbazepine.
Testosterone Injection Testosterone Injection Testosterone may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Oritavancin Injection Oritavancin Injection The metabolism of Almotriptan can be decreased when combined with Oritavancin.
Hydrocodone Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Suvorexant Suvorexant Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Edoxaban Edoxaban Almotriptan may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Methamphetamine Methamphetamine The metabolism of Almotriptan can be decreased when combined with Metamfetamine.
Tasimelteon Tasimelteon The risk or severity of adverse effects can be increased when Almotriptan is combined with Tasimelteon.
Riociguat Riociguat The metabolism of Riociguat can be decreased when combined with Almotriptan.
Secukinumab Injection Secukinumab Injection The metabolism of Almotriptan can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Almotriptan.
Lenvatinib Lenvatinib The metabolism of Almotriptan can be decreased when combined with Lenvatinib.
Naloxegol Naloxegol The metabolism of Almotriptan can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Almotriptan can be decreased when combined with Panobinostat.
Haloperidol Injection Haloperidol Injection The risk or severity of CNS depression can be increased when Almotriptan is combined with Haloperidol.
Amiloride Amiloride Amiloride may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Almotriptan may decrease the excretion rate of Macitentan which could result in a higher serum level.
Flibanserin Flibanserin The risk or severity of adverse effects can be increased when Almotriptan is combined with Flibanserin.
Rolapitant Rolapitant The metabolism of Almotriptan can be decreased when combined with Rolapitant.
Brexpiprazole Brexpiprazole The risk or severity of adverse effects can be increased when Almotriptan is combined with Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of adverse effects can be increased when Ziprasidone is combined with Almotriptan.
Cariprazine Cariprazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Cariprazine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Almotriptan may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Eluxadoline.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Almotriptan.
Ixazomib Ixazomib Almotriptan may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Rifapentine Rifapentine The metabolism of Almotriptan can be increased when combined with Rifapentine.
Lesinurad Lesinurad Almotriptan may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The metabolism of Almotriptan can be increased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection The risk or severity of adverse effects can be increased when Almotriptan is combined with Brivaracetam.
Cobicistat Cobicistat The metabolism of Almotriptan can be decreased when combined with Cobicistat.
Midodrine Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Almotriptan.
Selexipag Selexipag The metabolism of Selexipag can be decreased when combined with Almotriptan.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Almotriptan is combined with Pimavanserin.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of adverse effects can be increased when Almotriptan is combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Furosemide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib Rucaparib The metabolism of Almotriptan can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection Almotriptan may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Ribociclib Ribociclib The metabolism of Almotriptan can be decreased when combined with Ribociclib.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Almotriptan.
Doxepin (Insomnia) Doxepin (Insomnia) Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Doxepin.
Deutetrabenazine Deutetrabenazine Almotriptan may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Almotriptan may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Safinamide Safinamide The metabolism of Almotriptan can be decreased when combined with Safinamide.
Naldemedine Naldemedine Almotriptan may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The metabolism of Almotriptan can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Almotriptan can be decreased when combined with Enasidenib.
Benznidazole Benznidazole Almotriptan may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Almotriptan may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Letermovir Letermovir The metabolism of Almotriptan can be decreased when combined with Letermovir.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Almotriptan.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection Buprenorphine Injection Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide Apalutamide The metabolism of Apalutamide can be decreased when combined with Almotriptan.
Avatrombopag Avatrombopag The metabolism of Almotriptan can be increased when combined with Avatrombopag.
Baricitinib Baricitinib Almotriptan may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The therapeutic efficacy of Almotriptan can be increased when used in combination with Lofexidine.
Plazomicin Injection Plazomicin Injection Almotriptan may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The metabolism of Almotriptan can be decreased when combined with Eliglustat.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Almotriptan.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Almotriptan.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Almotriptan.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Almotriptan.
Dacomitinib Dacomitinib The metabolism of Almotriptan can be decreased when combined with Dacomitinib.
Stiripentol Stiripentol The metabolism of Almotriptan can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib The therapeutic efficacy of Almotriptan can be decreased when used in combination with Gilteritinib.
Glasdegib Glasdegib The metabolism of Glasdegib can be decreased when combined with Almotriptan.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Almotriptan.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Almotriptan.
Rifamycin Rifamycin The metabolism of Almotriptan can be decreased when combined with Rifamycin.
Prucalopride Prucalopride Almotriptan may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Almotriptan can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of hypertension can be increased when Almotriptan is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Alpelisib Alpelisib The metabolism of Almotriptan can be decreased when combined with Alpelisib.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Almotriptan is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Almotriptan.
Triclabendazole Triclabendazole The metabolism of Almotriptan can be decreased when combined with Triclabendazole.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Almotriptan.
Pitolisant Pitolisant The serum concentration of Almotriptan can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib The metabolism of Almotriptan can be decreased when combined with Fedratinib.
Phenytoin Injection Phenytoin Injection The metabolism of Almotriptan can be decreased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Almotriptan.
Lumateperone Lumateperone The risk or severity of adverse effects can be increased when Almotriptan is combined with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Lasmiditan.
Cenobamate Cenobamate The serum concentration of Almotriptan can be decreased when it is combined with Cenobamate.
Ozanimod Ozanimod The metabolism of Ozanimod can be decreased when combined with Almotriptan.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Almotriptan.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Almotriptan.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be increased when it is combined with Almotriptan.
Lemborexant Lemborexant The risk or severity of adverse effects can be increased when Almotriptan is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Almotriptan.
Pralsetinib Pralsetinib The metabolism of Almotriptan can be decreased when combined with Pralsetinib.
Opicapone Opicapone The metabolism of Almotriptan can be decreased when combined with Opicapone.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Almotriptan can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Almotriptan is combined with Naxitamab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Viloxazine.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Theophylline Theophylline The metabolism of Almotriptan can be decreased when combined with Theophylline.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Indomethacin Indomethacin Indomethacin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Mefenamic Acid Mefenamic Acid The metabolism of Almotriptan can be decreased when combined with Mefenamic acid.
Naproxen Naproxen Naproxen may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Trazodone Trazodone The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Almotriptan.
Isotretinoin Isotretinoin Almotriptan may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Hydroxyurea Hydroxyurea The metabolism of Almotriptan can be decreased when combined with Hydroxyurea.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Phenobarbital Phenobarbital The metabolism of Almotriptan can be increased when combined with Phenobarbital.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Almotriptan.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Almotriptan.
Primidone Primidone The risk or severity of adverse effects can be increased when Primidone is combined with Almotriptan.
Methsuximide Methsuximide The risk or severity of adverse effects can be increased when Almotriptan is combined with Methsuximide.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Almotriptan is combined with Diethylpropion.
Chlorpromazine Chlorpromazine The metabolism of Almotriptan can be decreased when combined with Chlorpromazine.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Almotriptan.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Almotriptan.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Almotriptan.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Almotriptan.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Almotriptan.
Phenoxybenzamine Phenoxybenzamine The risk or severity of hypertension can be increased when Almotriptan is combined with Phenoxybenzamine.
Carmustine Carmustine Carmustine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Amantadine Amantadine The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Almotriptan.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Almotriptan.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Almotriptan.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Almotriptan.
Bromocriptine Bromocriptine Almotriptan may increase the vasoconstricting activities of Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of hypertension can be increased when Orciprenaline is combined with Almotriptan.
Tranylcypromine Tranylcypromine The metabolism of Almotriptan can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Almotriptan can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The metabolism of Almotriptan can be decreased when combined with Procarbazine.
Ergoloid Mesylates Ergoloid Mesylates Ergoloid mesylate may increase the vasoconstricting activities of Almotriptan.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Prochlorperazine Prochlorperazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Prochlorperazine.
Thioridazine Thioridazine The metabolism of Almotriptan can be decreased when combined with Thioridazine.
Trifluoperazine Trifluoperazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Trifluoperazine.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Dapsone Dapsone The metabolism of Almotriptan can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The metabolism of Almotriptan can be decreased when combined with Sulfadiazine.
Oxycodone Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Almotriptan.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Almotriptan.
Oxybutynin Oxybutynin The metabolism of Almotriptan can be decreased when combined with Oxybutynin.
Benztropine Benztropine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Maprotiline Maprotiline Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Trihexyphenidyl Trihexyphenidyl Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The metabolism of Almotriptan can be decreased when combined with Perphenazine.
Azathioprine Azathioprine Almotriptan may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Fluphenazine Fluphenazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Fluphenazine.
Phentermine Phentermine The metabolism of Almotriptan can be decreased when combined with Phentermine.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Amoxapine Amoxapine The metabolism of Amoxapine can be decreased when combined with Almotriptan.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Hydrocortisone Hydrocortisone The metabolism of Almotriptan can be increased when combined with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Almotriptan can be decreased when combined with Doxorubicin.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Carbamazepine Carbamazepine Carbamazepine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Molindone Molindone The risk or severity of adverse effects can be increased when Almotriptan is combined with Molindone.
Methyldopa Methyldopa Almotriptan may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Almotriptan.
Prazosin Prazosin Almotriptan may decrease the antihypertensive activities of Prazosin.
Hydralazine Hydralazine Almotriptan may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine The metabolism of Almotriptan can be decreased when combined with Cimetidine.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Warfarin Warfarin Warfarin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Almotriptan is combined with Clonazepam.
Loperamide Loperamide The metabolism of Almotriptan can be decreased when combined with Loperamide.
Promethazine Promethazine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Promethazine.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Almotriptan can be increased when combined with Griseofulvin.
Digoxin Digoxin Almotriptan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Almotriptan.
Chloroquine Chloroquine The metabolism of Almotriptan can be decreased when combined with Chloroquine.
Quinine Quinine The metabolism of Almotriptan can be decreased when combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Almotriptan.
Triamterene Triamterene Triamterene may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Sulfinpyrazone Sulfinpyrazone The metabolism of Almotriptan can be decreased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital The metabolism of Almotriptan can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Almotriptan.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Almotriptan.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Almotriptan.
Probenecid Probenecid The metabolism of Probenecid can be increased when combined with Almotriptan.
Quinidine Quinidine The metabolism of Almotriptan can be decreased when combined with Quinidine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Almotriptan.
Isoniazid Isoniazid The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Isoniazid.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Rifampin Rifampin The metabolism of Almotriptan can be increased when combined with Rifampicin.
Disopyramide Disopyramide Disopyramide may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Valproic Acid Valproic Acid The metabolism of Almotriptan can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Almotriptan can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Almotriptan.
Levothyroxine Levothyroxine The metabolism of Almotriptan can be decreased when combined with Levothyroxine.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Methimazole Methimazole The metabolism of Almotriptan can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide Chlorpropamide may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Almotriptan.
Tolazamide Tolazamide Tolazamide may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Dextromethorphan Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Almotriptan.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Almotriptan is combined with Cyclobenzaprine.
Niacin Niacin The metabolism of Almotriptan can be decreased when combined with Niacin.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Almotriptan.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Cyproheptadine Cyproheptadine The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Almotriptan.
Clemastine Clemastine The metabolism of Almotriptan can be decreased when combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of adverse effects can be increased when Almotriptan is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Almotriptan.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Almotriptan.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Almotriptan is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Almotriptan.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Almotriptan.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Almotriptan.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Almotriptan can be decreased when combined with Propranolol.
Minoxidil Minoxidil Almotriptan may decrease the antihypertensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine The metabolism of Almotriptan can be decreased when combined with Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Almotriptan.
Spironolactone Spironolactone The metabolism of Almotriptan can be decreased when combined with Spironolactone.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Phytonadione Phytonadione Almotriptan may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Nadolol Nadolol Almotriptan may decrease the excretion rate of Nadolol which could result in a higher serum level.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Almotriptan.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Almotriptan.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Almotriptan.
Flavoxate Flavoxate Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Fluorouracil Injection Fluorouracil Injection The metabolism of Almotriptan can be decreased when combined with Fluorouracil.
Colchicine Colchicine The metabolism of Almotriptan can be decreased when combined with Colchicine.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Dacarbazine Dacarbazine Dacarbazine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Almotriptan.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Ketoconazole Ketoconazole The metabolism of Almotriptan can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Almotriptan is combined with Pyrantel.
Captopril Captopril Almotriptan may decrease the antihypertensive activities of Captopril.
Isoxsuprine Isoxsuprine The risk or severity of hypertension can be increased when Almotriptan is combined with Isoxsuprine.
Vinblastine Vinblastine The metabolism of Almotriptan can be decreased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Metoprolol Metoprolol The metabolism of Almotriptan can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Thiothixene Thiothixene The risk or severity of adverse effects can be increased when Almotriptan is combined with Thiothixene.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Almotriptan.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Almotriptan.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Almotriptan.
Dicyclomine Dicyclomine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Hyoscyamine Hyoscyamine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Propantheline may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Trimethoprim Trimethoprim The metabolism of Almotriptan can be decreased when combined with Trimethoprim.
Diltiazem Diltiazem The metabolism of Almotriptan can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The metabolism of Almotriptan can be decreased when combined with Nifedipine.
Timolol Timolol Timolol may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Verapamil Verapamil The metabolism of Almotriptan can be decreased when combined with Verapamil.
Atenolol Atenolol The metabolism of Almotriptan can be decreased when combined with Atenolol.
Pindolol Pindolol The risk or severity of adverse effects can be increased when Almotriptan is combined with Pindolol.
Cisplatin Injection Cisplatin Injection Almotriptan may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Bumetanide Bumetanide Bumetanide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Glipizide Glipizide Almotriptan may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide Indapamide Indapamide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin Amoxicillin Almotriptan may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pentoxifylline may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Labetalol Labetalol The metabolism of Almotriptan can be decreased when combined with Labetalol.
Auranofin Auranofin Almotriptan may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Gemfibrozil Gemfibrozil The metabolism of Almotriptan can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The risk or severity of hypertension can be increased when Guanabenz is combined with Almotriptan.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Pimozide Pimozide The metabolism of Almotriptan can be decreased when combined with Pimozide.
Enalapril Enalapril Almotriptan may decrease the antihypertensive activities of Enalapril.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Almotriptan.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Buspirone Buspirone The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Almotriptan.
Lovastatin Lovastatin The metabolism of Almotriptan can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Fluoxetine Fluoxetine The serum concentration of Almotriptan can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine Almotriptan may decrease the antihypertensive activities of Nimodipine.
Clozapine Clozapine The metabolism of Clozapine can be decreased when combined with Almotriptan.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Almotriptan is combined with Estazolam.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Almotriptan.
Didanosine Didanosine Didanosine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Clarithromycin Clarithromycin The metabolism of Almotriptan can be decreased when combined with Clarithromycin.
Benazepril Benazepril Almotriptan may decrease the antihypertensive activities of Benazepril.
Etodolac Etodolac Etodolac may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Felodipine Felodipine The metabolism of Almotriptan can be decreased when combined with Felodipine.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Quinapril Quinapril Almotriptan may decrease the antihypertensive activities of Quinapril.
Ramipril Ramipril Almotriptan may decrease the antihypertensive activities of Ramipril.
Simvastatin Simvastatin The metabolism of Almotriptan can be decreased when combined with Simvastatin.
Amlodipine Amlodipine Almotriptan may decrease the antihypertensive activities of Amlodipine.
Itraconazole Itraconazole The metabolism of Almotriptan can be decreased when combined with Itraconazole.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Rifabutin Rifabutin The metabolism of Almotriptan can be increased when combined with Rifabutin.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Almotriptan.
Bisoprolol Bisoprolol Bisoprolol may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Zolpidem Zolpidem Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin Almotriptan may decrease the antihypertensive activities of Doxazosin.
Terazosin Terazosin Almotriptan may decrease the antihypertensive activities of Terazosin.
Isradipine Isradipine Isradipine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Omeprazole Omeprazole The metabolism of Almotriptan can be decreased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Almotriptan can be decreased when combined with Cisapride.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Almotriptan is combined with Gabapentin.
Fluvastatin Fluvastatin The metabolism of Almotriptan can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The metabolism of Almotriptan can be decreased when combined with Venlafaxine.
Fluvoxamine Fluvoxamine The metabolism of Fluvoxamine can be decreased when combined with Almotriptan.
Nefazodone Nefazodone The metabolism of Almotriptan can be decreased when combined with Nefazodone.
Lamotrigine Lamotrigine Lamotrigine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Losartan Losartan The metabolism of Almotriptan can be decreased when combined with Losartan.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Tramadol Tramadol The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Almotriptan.
Vinorelbine Injection Vinorelbine Injection The metabolism of Almotriptan can be decreased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Moexipril Moexipril Almotriptan may decrease the antihypertensive activities of Moexipril.
Lansoprazole Lansoprazole The metabolism of Almotriptan can be decreased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Almotriptan.
Nicardipine Nicardipine The metabolism of Almotriptan can be decreased when combined with Nicardipine.
Bupropion Bupropion The metabolism of Almotriptan can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Almotriptan can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Saquinavir can be decreased when combined with Almotriptan.
Metformin Metformin Metformin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Nisoldipine Nisoldipine Almotriptan may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Riluzole Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Almotriptan.
Acarbose Acarbose Acarbose may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Anastrozole Anastrozole The metabolism of Anastrozole can be decreased when combined with Almotriptan.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Ritonavir Ritonavir The metabolism of Almotriptan can be decreased when combined with Ritonavir.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Almotriptan.
Zafirlukast Zafirlukast The metabolism of Almotriptan can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Mirtazapine Mirtazapine Almotriptan may increase the serotonergic activities of Mirtazapine.
Trandolapril Trandolapril Almotriptan may decrease the antihypertensive activities of Trandolapril.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Almotriptan.
Valsartan Valsartan Almotriptan may decrease the antihypertensive activities of Valsartan.
Pramipexole Pramipexole Almotriptan may increase the sedative activities of Pramipexole.
Donepezil Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Almotriptan.
Nelfinavir Nelfinavir The metabolism of Almotriptan can be decreased when combined with Nelfinavir.
Loratadine Loratadine The metabolism of Almotriptan can be decreased when combined with Loratadine.
Carvedilol Carvedilol Almotriptan may decrease the antihypertensive activities of Carvedilol.
Nilutamide Nilutamide The metabolism of Almotriptan can be decreased when combined with Nilutamide.
Flutamide Flutamide Flutamide may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Selegiline Selegiline The metabolism of Almotriptan can be decreased when combined with Selegiline.
Bicalutamide Bicalutamide The metabolism of Almotriptan can be decreased when combined with Bicalutamide.
Sertraline Sertraline The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.
Propafenone Propafenone The metabolism of Almotriptan can be decreased when combined with Propafenone.
Raloxifene Raloxifene The metabolism of Almotriptan can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Almotriptan can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin Tamsulosin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Ropinirole Ropinirole Almotriptan may increase the sedative activities of Ropinirole.
Finasteride Finasteride The risk or severity of hypertension can be increased when Almotriptan is combined with Finasteride.
Quetiapine Quetiapine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Almotriptan.
Paroxetine Paroxetine The risk or severity of serotonin syndrome can be increased when Paroxetine is combined with Almotriptan.
Tolcapone Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Almotriptan.
Citalopram Citalopram The risk or severity of adverse effects can be increased when Almotriptan is combined with Citalopram.
Capecitabine Capecitabine Almotriptan may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz Efavirenz The metabolism of Almotriptan can be decreased when combined with Efavirenz.
Abacavir Abacavir Almotriptan may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Almotriptan can be decreased when combined with Sildenafil.
Pioglitazone Pioglitazone The metabolism of Almotriptan can be decreased when combined with Pioglitazone.
Celecoxib Celecoxib The metabolism of Almotriptan can be decreased when combined with Celecoxib.
Rosiglitazone Rosiglitazone The metabolism of Almotriptan can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
Thalidomide Thalidomide Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Nateglinide Nateglinide Nateglinide may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Galantamine Galantamine The metabolism of Almotriptan can be decreased when combined with Galantamine.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Almotriptan is combined with Levetiracetam.
Rabeprazole Rabeprazole The metabolism of Almotriptan can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Almotriptan can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists

Still Confused? Ask the pharmacist a question here!